Trials / Completed
CompletedNCT00565461
LT Vaccine Patch Self-Administration Study
A Phase 2, Randomized, Open-Label Study to Compare the Immunogenicity and Safety of a Self-Administered LT Vaccine Patch With an LT Vaccine Patch Administered by a Clinician
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Intercell USA, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the immune responses achieved following self-administered heat-labile enterotoxin of E. coli (LT) vaccination by transcutaneous immunization compared to the immune responses achieved by clinician-administered vaccination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | heat-labile enterotoxin of E. coli (LT) | 37.5ug patch applied on either the deltoid or the thigh |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-07-01
- Completion
- 2008-08-01
- First posted
- 2007-11-30
- Last updated
- 2020-03-30
- Results posted
- 2014-04-21
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00565461. Inclusion in this directory is not an endorsement.